184 related articles for article (PubMed ID: 11446889)
1. Systemic and splanchnic hemodynamics following hemorrhage and volume restitution with Haemaccel in portal hypertensive rats: the effect of propranolol.
Hilzenrat N; Arish A; Yaari A; Sikuler E
J Gastroenterol Hepatol; 2001 Jul; 16(7):796-800. PubMed ID: 11446889
[TBL] [Abstract][Full Text] [Related]
2. Portal hypertension and blood viscosity.
Sikuler E
J Clin Gastroenterol; 2007; 41 Suppl 3():S262-5. PubMed ID: 17975475
[TBL] [Abstract][Full Text] [Related]
3. Acute hemodynamic changes following hemorrhage and volume restitution, using a low viscosity plasma expander, in anesthetized portal hypertensive rats.
Hilzenrat N; Arish A; Yaari A; Sikuler E
J Hepatol; 1999 Nov; 31(5):874-9. PubMed ID: 10580585
[TBL] [Abstract][Full Text] [Related]
4. Late hemodynamic changes following controlled hemorrhage and volume restitution with blood or Haemaccel in anesthetized portal hypertensive rats.
Hilzenrat N; Yaari A; Sikuler E
J Gastroenterol Hepatol; 2002 Dec; 17(12):1317-22. PubMed ID: 12423278
[TBL] [Abstract][Full Text] [Related]
5. Blood viscosity, hemodynamics and vascular hindrance in a rat model of acute controlled bleeding and volume restitution with blood or Haemaccel.
Hilzenrat N; Arish A; Yaari A; Almog Y; Sikuler E
Acta Anaesthesiol Scand; 2001 Mar; 45(3):371-6. PubMed ID: 11207476
[TBL] [Abstract][Full Text] [Related]
6. Splanchnic and systemic hemodynamics in portal hypertensive rats during hemorrhage and blood volume restitution.
Kravetz D; Sikuler E; Groszmann RJ
Gastroenterology; 1986 May; 90(5 Pt 1):1232-40. PubMed ID: 3956942
[TBL] [Abstract][Full Text] [Related]
7. Discrepancy between portal pressure and systemic hemodynamic changes after incremental doses of propranolol in awake portal hypertensive rats.
Koshy A; Girod C; Lee SS; Hadengue A; Cerini R; Lebrec D
Hepatology; 1989 Feb; 9(2):269-73. PubMed ID: 2912829
[TBL] [Abstract][Full Text] [Related]
8. Effects of alpha 1 and beta-adrenergic antagonists and 5-hydroxytryptamine receptor antagonist on portal-systemic collateral vascular resistance in conscious rats with portal hypertension.
Koshy A; Sekiyama T; Hadengue A; Cerini R; Braillon A; Lebrec D
J Gastroenterol Hepatol; 1992; 7(5):449-54. PubMed ID: 1391726
[TBL] [Abstract][Full Text] [Related]
9. Haemodynamic effects of octreotide in portal hypertensive rats receiving propranolol.
Moreau R; Cailmail S; Gadano A; Valla D; Lebrec D
Aliment Pharmacol Ther; 1997 Aug; 11(4):775-9. PubMed ID: 9305488
[TBL] [Abstract][Full Text] [Related]
10. Effects of terlipressin on hemodynamics and oxygen content in conscious portal vein stenosed and cirrhotic rats receiving propranolol.
Lebrec D; Moreau R; Cailmail S; Sogni P; Oberti F; Hadengue A
J Hepatol; 1993 Jan; 17(1):102-7. PubMed ID: 8445208
[TBL] [Abstract][Full Text] [Related]
11. Propranolol decreases portal pressure without changing portocollateral resistance in cirrhotic rats.
Pizcueta MP; de Lacy AM; Kravetz D; Bosch J; Rodés J
Hepatology; 1989 Dec; 10(6):953-7. PubMed ID: 2583690
[TBL] [Abstract][Full Text] [Related]
12. Effect of selective blockade of beta 2-adrenergic receptors on portal and systemic hemodynamics in a portal hypertensive rat model.
Kroeger RJ; Groszmann RJ
Gastroenterology; 1985 Apr; 88(4):896-900. PubMed ID: 2857673
[TBL] [Abstract][Full Text] [Related]
13. Acute effect of propranolol on splanchnic circulation in normal and portal hypertensive rats.
Calès P; Braillon A; Girod C; Lebrec D
J Hepatol; 1985; 1(4):349-57. PubMed ID: 4056347
[TBL] [Abstract][Full Text] [Related]
14. Hyperdynamic circulation in portal-hypertensive rat model: a primary factor for maintenance of chronic portal hypertension.
Vorobioff J; Bredfeldt JE; Groszmann RJ
Am J Physiol; 1983 Jan; 244(1):G52-7. PubMed ID: 6849394
[TBL] [Abstract][Full Text] [Related]
15. Hemodynamic effects of eight-day octreotide and propranolol administration in portal hypertensive rats.
Huang YT; Cheng YR; Lin HC; Hou MC; Lee SD; Hong CY
Dig Dis Sci; 1998 Feb; 43(2):358-64. PubMed ID: 9512131
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats.
Fernandez M; Mejias M; Angermayr B; Garcia-Pagan JC; Rodés J; Bosch J
J Hepatol; 2005 Jul; 43(1):98-103. PubMed ID: 15893841
[TBL] [Abstract][Full Text] [Related]
17. The effect of the combination of nitroglycerin and propranolol on splanchnic and systemic hemodynamics in a portal hypertensive rat model.
Kroeger RJ; Groszmann RJ
Hepatology; 1985; 5(3):425-30. PubMed ID: 3922868
[TBL] [Abstract][Full Text] [Related]
18. Nipradilol, a new beta-blocker with vasodilatory properties, in experimental portal hypertension: a comparative haemodynamic study with propranolol.
Um S; Nishida O; Tokubayashi M; Kimura F; Kita T
J Gastroenterol Hepatol; 1993; 8(5):414-9. PubMed ID: 8105997
[TBL] [Abstract][Full Text] [Related]
19. Hemodynamic effects of chronic tetrandrine and propranolol administration on portal hypertensive rats.
Huang YT; Liu TB; Lin HC; Yang MC; Hong CY
Pharmacology; 1997 May; 54(5):225-31. PubMed ID: 9380768
[TBL] [Abstract][Full Text] [Related]
20. Hemodynamic effects of blood volume restitution following a hemorrhage in rats with portal hypertension due to cirrhosis of the liver: influence of the extent of portal-systemic shunting.
Kravetz D; Bosch J; Arderiu M; Pilar Pizcueta M; Rodés J
Hepatology; 1989 Jun; 9(6):808-14. PubMed ID: 2714733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
